PMN: ProMIS Neurosciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 21.12
Enterprise Value ($M) 7.83
Book Value ($M) 16.49
Book Value / Share 0.50
Price / Book 1.28
NCAV ($M) 16.49
NCAV / Share 0.50
Price / NCAV 1.28

Profitability (mra)
Return on Invested Capital (ROIC) 0.17
Return on Assets (ROA) 0.78
Return on Equity (ROE) 36.04

Liquidity (mrq)
Quick Ratio 8.52
Current Ratio 8.52

Balance Sheet (mrq) ($M)
Current Assets 18.91
Assets 18.91
Liabilities 2.42
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -16.83
Net Income 2.78

Cash Flow Statement (mra) ($M)
Cash From Operations -27.18
Cash from Investing -0.00
Cash from Financing 27.88

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Armistice Capital, Llc 7.68 -5.99
02-14 13G/A Great Point Partners Llc 9.99 10.89
11-06 13G/A Sclar Jeremy M. 19.10 77.92
11-05 13G/A Gordon Michael S 14.00 77.07
10-16 13G Shaf QIC LLC 9.99

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-31 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 56,818 87,285 65.09
2025-04-16 2,080 11,473 18.13
2025-04-15 338 6,012 5.62

(click for more detail)

Similar Companies
PHIO – Phio Pharmaceuticals Corp. PLUR – Pluri Inc.
PMCB – PharmaCyte Biotech, Inc. PRFX – PainReform Ltd.
PROK – ProKidney Corp.


Financial data and stock pages provided by
Fintel.io